Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 5.2 CHF 1.96% Market Closed
Market Cap: 191.6m CHF
Have any thoughts about
Molecular Partners AG?
Write Note

Molecular Partners AG
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Molecular Partners AG
Additional Paid In Capital Peer Comparison

Comparables:
ADCT
ACIU
CRSP
BSLN
KURN

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Molecular Partners AG
SIX:MOLN
Additional Paid In Capital
CHf367.5m
CAGR 3-Years
1%
CAGR 5-Years
15%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Additional Paid In Capital
$1.2B
CAGR 3-Years
6%
CAGR 5-Years
21%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Additional Paid In Capital
CHf476.1m
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Additional Paid In Capital
$3.3B
CAGR 3-Years
8%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Additional Paid In Capital
CHf1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Molecular Partners AG's Additional Paid In Capital?
Additional Paid In Capital
367.5m CHF

Based on the financial report for Jun 30, 2024, Molecular Partners AG's Additional Paid In Capital amounts to 367.5m CHF.

What is Molecular Partners AG's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
15%

Over the last year, the Additional Paid In Capital growth was 1%. The average annual Additional Paid In Capital growth rates for Molecular Partners AG have been 1% over the past three years , 15% over the past five years .

Back to Top